At 8.5x forward earnings with a PEG Forward of 0.3, the stock screens optically cheap, but the underlying fundamentals are deteriorating fast. EPS of 17.9 collapsing to an estimated -$0.50 next year signals a violent earnings reset, which explains why the trailing P/E is not even usable and why Operating Margin sits at -5.60%. A Price/Sales ratio of 1 and Market Cap of $2,068M suggest the market is not assigning a premium multiple, yet the combination of negative ROIC at -1.50% and a Piotroski F-Score of 3 implies weak financial quality. This is not a classic mispricing; it’s a balance sheet and profitability story in transition, and without a reported Altman Z-Score, the true solvency cushion remains unclear.